. home.aspx


Enforcement Actions Against Sartan Manufacturers

October 31, 2019 / BARBARA W. UNGE

Health authorities worldwide have overseen the recall of many ‘sartan’ products in the past few years.  These recalls began in the US as early as 2013 with a recall of product by Teva Pharmaceuticals.  Authorities in the US, EMA, Canada, and Australia, just to name a few, have taken enforcement actions and implemented drug product recalls. Because the impurity originated with the API, and because the generic version of the drug(s) in question are manufactured by a variety of firms, this impacts many products from many companies.  While the initial problem began with a valsartan API, studies have demonstrated that this may include many other ‘sartan’ products and other related nitrosamine impurities.